LLY (xyz) on Hyperliquid
LLY (xyz) on Hyperliquid — price $1,151.7 (-0.10% 24h), funding +0.0006%/1h, open interest $6.4M, 24h volume $211.8K. Annualized funding +5.5%. Source: Hyperliquid official · as of 2026-09-07 00:31 UTC
Open/closed is computed server-side and the page is cached for up to an hour, so the status can lag — read the times above.
- Max leverage
- 10×
- Open interest cap
- Capped — value not published
- Oracle basis (underlying)
- LLY / USD
- Margin mode
- Normal Isolated
- Discovery bound
- ±10%
- Funding rate multiplier
- 0.5
- External pricing session
- 24/5, from Sunday 8:00 PM ET to Friday 8:00 PM ET
- Internal pricing session
- Friday 8:00 PM to Sunday 8:00 PM ET, and follows equities holidays & trading hours.
Source: trade[XYZ] operator documentation (Specification Index, Holiday Closures, Roll Schedules), synced weekly. · 2026-09-06
The LLY (xyz) perpetual trades 24/7 on Hyperliquid, including while NYSE / Nasdaq is closed. While the underlying market is shut the oracle stops using external quotes and advances an internal price anchored to the last external print, snapping back to the external reference once quotes resume. The Stocks hub explains how that works for this asset class.
Daily closes spanning the full history since listing. Switch to 1M for finer hourly-snapshot detail (our moat, collected since 2026-06-14).
/api/hl/markets/xyz-lly-perp/history?format=csv&from=2026-06-14&to=2026-09-07&granularity=dailyDaily/weekly/monthly rollups from D1. File header carries the attribution line.
Historical data is free to cite and reuse with attribution — link this page or hyperacademy.io.
Predicted funding (Binance/Bybit normalized to a 1h basis). Informational only — not investment advice.
xyz:LLY is a perpetual futures market on Hyperliquid's HIP-3 builder-dex framework that provides synthetic, leveraged price exposure to Eli Lilly, one of the largest pharmaceutical companies globally. This is not the Eli Lilly stock itself — it is a derivative tracking the company's price via an oracle feed, built and configured by xyz, an independent third-party builder-dex operating under HIP-3 rather than Hyperliquid's core protocol. Because xyz sets its own market parameters — oracle source, funding mechanism, margin requirements — traders take on builder-specific risk in addition to standard leveraged-derivatives risk, including how deep the on-chain liquidity is for this specific market. Max leverage on xyz:LLY is 10x, which magnifies both potential gains and losses. Given pharmaceutical stocks can move sharply on clinical trial or regulatory news, careful position sizing and awareness of liquidation thresholds are important.
Does xyz:LLY give me any rights as an Eli Lilly shareholder?
No. It's a synthetic perpetual tracking Eli Lilly's price through an oracle — you receive no shares, dividends, or shareholder rights, only a leveraged derivative position on xyz.
Why might xyz:LLY be riskier than a standard Hyperliquid perp?
As a HIP-3 builder-dex market, xyz:LLY adds builder-specific risk on top of normal perp risk — the accuracy of its oracle feed, the builder's own parameter choices, and this market's specific liquidity depth.
How does pharma-sector volatility interact with 10x leverage here?
Pharmaceutical stocks can gap sharply on trial results or regulatory decisions. Combined with 10x leverage, a fast adverse move can trigger liquidation quickly, so conservative sizing matters more on volatile underlyings.
What is the LLY (xyz) funding rate on Hyperliquid?
As of the latest snapshot, LLY (xyz) funding is +0.0006%/1h (≈ +5.5% annualized). Hyperliquid settles funding every hour. As of 2026-09-07 00:31 UTC.
What are LLY (xyz)'s 24h volume and open interest?
LLY (xyz) currently has $211.8K in 24h volume and $6.4M in open interest. As of 2026-09-07 00:31 UTC.
What is LLY (xyz)'s all-time high on Hyperliquid?
LLY (xyz)'s all-time high is $1,293.9 on 2026-08-19; the all-time low is $851.110 on 2026-04-30. The 52-week range is $851.110–$1,293.9. As of 2026-09-07 00:31 UTC.